WHO has identified a number of experimental Ebola treatments and vaccine candidates for evaluation in clinical trials as global health authorities intensify efforts to contain the ongoing outbreak in Africa.

According to the WHO, the selected drugs and vaccine candidates will undergo clinical testing to generate critical data on their safety, effectiveness, and potential role in controlling the spread of Ebola Virus Disease . The agency has been working closely with international experts, researchers, and regulatory authorities to assess promising medical countermeasures that could strengthen outbreak response efforts.

The move comes as global health agencies seek faster and more effective tools to combat Ebola, a highly infectious disease that can cause severe illness and death. WHO estimates indicate that Ebola outbreaks have historically recorded fatality rates ranging from 25% to 90%, depending on the virus strain, healthcare access, and speed of intervention.

While approved vaccines and treatments have significantly improved survival rates in recent years, health experts say additional options are needed to address emerging outbreaks and improve preparedness. The WHO noted that clinical trials are essential to determine whether newer candidates can provide broader protection and better treatment outcomes.

The latest outbreak has prompted heightened surveillance, screening measures, and public health preparedness efforts across several countries. Global health authorities continue to emphasize early detection, contact tracing, isolation of suspected cases, and rapid medical intervention as the most effective strategies for controlling transmission.

Public health experts believe the identification of additional treatment and vaccine candidates represents an important step toward strengthening global Ebola preparedness. The findings from the upcoming trials are expected to contribute to future outbreak response strategies and support international efforts to reduce mortality associated with the disease.

The WHO said it will continue working with governments, research institutions, and international partners to accelerate evidence generation and ensure that effective medical tools are available wherever Ebola outbreaks occur.